Generic Tc 99m Sestamibi Cardiac Radiotracer Cleared
October 31, 2008
The FDA granted approval for Covidien’s generic kit for the preparation of technetium Tc99m Sestamibi injection use for nuclear myocardial perfusion imaging.
Covidien’s product is a generic version of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease. The branded product is utilized in nearly 60 percent of the 15 million myocardial perfusion imaging studies performed in the U.S. annually.
More like this
- Lantheus to Use Competitive Pricing Against Generic Cardiac Agents
- FDA Clears Covidien’s Generic Tc 99m Sestamibi Cardiac Radiotracer
- Health Canada Approves Covidien's Generic Myocardial Perfusion Imaging Kit
- Covidien Granted Tentative FDA Approval for Generic Myocardial Perfusion
- Covidien Granted Tentative FDA Approval for Generic Myocardial Perfusion